Search results
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 5 days agoPfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected,...
Pfizer’s reported net income declines 44% in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 3 days agoPfizer’s reported net income stood at $3.11bn in the first quarter (Q1) of 2024, marking a decrease of 44% from $5.54bn posted in Q1 2023. The...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 4 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 4 days agoPfizer shares rose more than 6% Wednesday afternoon after the company's first-quarter results beat Wall Street analyst estimates and the drugmaker raised...
Pfizer: Q1 Earnings Snapshot
Midland Reporter-Telegram· 4 days agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter...
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug
Morningstar· 6 days agoPfizer and Genmab on Monday said they had received full approval from U.S. regulators for their treatment for certain forms of cervical cancer. The companies' drug Tivdak ...
Stocks making the biggest moves premarket: Pfizer, CVS, Amazon, Starbucks and more
CNBC· 4 days agoThese are some of the stocks posting the largest moves in early hours trading.
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 4 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
Drew Panayiotou
Forbes· 8 hours agoBecause Panayiotou approaches marketing with, what he told Forbes is the "audacity to do what others consider impossible." Charged by Pfizer's CEO with ensuring the brand ...
